CuraVac Europe
Biotechnology ResearchView the employees at
CuraVac Europe-
Samuel Osumba Project Manag chez CuraVac Europe
-
Koekelberg, Brussels Region, Belgium
-
Rising Star
-
Overview
CuraVac is a clinical-stage biotech developing a new class of targeted therapeutic vaccines / immunotherapies for autoimmune diseases. Our first therapeutic vaccine is for myasthenia gravis (MG). Preclinical work is ongoing for other autoimmune diseases including MS and GBS. Future studies will focus on Graves' diease, Hashimoto's disease, Type 1 Diabetes, ...